| Viatris is a healthcare company. Co.'s portfolio comprises of approved molecules across a range of therapeutic areas, including brands, generic, complex generic and biosimilars. From cardiovascular health to oncology, Co. provides treatment options across therapeutic areas covering a variety of non-communicable and infectious diseases. Co. also provides support services such as diagnostic clinics, educational seminars and digital tools. Co. provides a range of treatment options across all its therapeutic areas, with several categories containing several products in a range of dosage forms, formulations and delivery systems that allow physicians to tailor care for optimal treatment. We show 11 historical shares outstanding datapoints in our VTRS shares outstanding history coverage, used to compute VTRS market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing VTRS market cap history over the course of time is important for investors
interested in comparing VTRS's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of VTRS versus a peer is one thing; comparing
VTRS market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like VTRS can fluctuate over the course of history.
With this page we aim to empower investors researching VTRS by allowing them to research the VTRS market cap history.